Jane F Barlow

CIK 1736026 · last filed 2025-06-06

Jane F Barlow is a corporate insider who has filed 17 SEC Form 4 insider transactions across 5 companies since 2018. The most recent filing, for SERA, was dated Jun 6, 2025. Across all open-market trades the lifetime net is +$10.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $49.4K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$49.4K

Companies

5

Total Filings

17

Lifetime Open-Market Net

$10.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SERA Director 22,713 $1.87 $42.5K $0 4 2025-06-06
Viracta Therapeutics, Inc. (VIRX) Delisted Director $0.01 $0 4 2024-06-24
CONTRAFECT Corp (CFRX) Delisted Director $0.05 $0 2 2022-05-18
MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Director $0 3 2020-10-01
TXMD Director 3,144 $2.20 $6.9K $10.0K 4 2019-08-14

Recent Filings

17 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-06-06 SERA Grant (A) +15,596 $0 EDGAR
2024-06-24 Viracta Therapeutics, Inc. (VIRX) Delisted Grant (A) $0 EDGAR
2024-06-07 SERA Grant (A) +7,117 $0 EDGAR
2023-07-07 SERA Grant (A) $0 EDGAR
2023-06-09 Viracta Therapeutics, Inc. (VIRX) Delisted Grant (A) $0 EDGAR
2022-06-10 Viracta Therapeutics, Inc. (VIRX) Delisted Grant (A) $0 EDGAR
2022-05-18 CONTRAFECT Corp (CFRX) Delisted Grant (A) $0 EDGAR
2022-04-12 SERA Grant (A) $0 EDGAR
2021-08-17 Viracta Therapeutics, Inc. (VIRX) Delisted Grant (A) $0 EDGAR
2021-02-11 CONTRAFECT Corp (CFRX) Delisted Grant (A) $0 EDGAR
Showing 110 of 17
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.